Correction to: FDA and EMA Biosimilar Approvals.

Journal

Journal of general internal medicine
ISSN: 1525-1497
Titre abrégé: J Gen Intern Med
Pays: United States
ID NLM: 8605834

Informations de publication

Date de publication:
05 Dec 2019
Historique:
entrez: 7 12 2019
pubmed: 7 12 2019
medline: 7 12 2019
Statut: aheadofprint

Résumé

This paper published with several formatting errors. They have been corrected and the paper has re-published.

Identifiants

DOI: 10.1007/s11606-019-05558-7 PMID: 31808127
pubmed: 31808127
doi: 10.1007/s11606-019-05558-7
pii: 10.1007/s11606-019-05558-7
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : ErratumFor

Auteurs

Emily H Jung (EH)

Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Ameet Sarpatwari (A)

Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. asarpatwari@bwh.harvard.edu.

Aaron S Kesselheim (AS)

Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Michael S Sinha (MS)

Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.

Classifications MeSH